TET2 and cardiomyopathy: Taken together, our findings indicate that SARS-CoV-2 infection is involved in the epitranscriptomic modulation of TET2 expression in hiPSC-CMs, suggesting that TET2-driven epitranscriptomic targets play some roles in the context of SARS-CoV-2-induced cardiomyopathy.